Hazel Hunt - 28 Sep 2022 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Chief Scientific Officer
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Hazel Hunt
Issuer symbol
CORT
Transactions as of
28 Sep 2022
Net transactions value
-$677,122
Form type
4
Filing time
30 Sep 2022, 16:30:23 UTC
Previous filing
15 Feb 2023
Next filing
09 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Options Exercise $104,000 +50,000 +94% $2.08* 103,143 28 Sep 2022 Direct
transaction CORT Common Stock Tax liability $781,122 -29,997 -29% $26.04 73,146 28 Sep 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CORT Stock option (right to buy) Options Exercise $0 -50,000 -100% $0.000000* 0 28 Sep 2022 Common Stock 50,000 $2.08 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were withheld so the Reporting Person could satisfy the exercise price and the withholding of taxes arising from a net (cashless) exercise of stock options. The options subject to the net exercise were to expire on January 30, 2023.
F2 Fully exercisable.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.